TheEdgeResearch
Home / Stocks / NTRA

Natera, Inc. (NTRA)

NASDAQ Healthcare Medical - Diagnostics & Research
$265.38 ▼ -3.36%
Market Cap
$38.01B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.50
52-Wk Range
136.21-288.04
CEO
Steven Leonard Chapman
Country
US
Currency
USD

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, …

Open full interactive analysis & DCF →